Valuation: Danaher Corporation

Market Cap 155B 141B 130B 118B 222B 14,356B 233B 1,584B 629B 7,841B 582B 569B 24,608B P/E 2026 *
35x
P/E 2027 * 29.3x
Enterprise Value 176B 160B 147B 134B 252B 16,261B 264B 1,794B 713B 8,882B 659B 645B 27,875B EV / Sales 2026 *
6.69x
EV / Sales 2027 * 6.05x
Free-Float
70.56%
Yield 2026 *
0.66%
Yield 2027 * 0.72%
1 day-3.16%
1 week-5.43%
Current month-5.11%
1 month-1.73%
3 months+2.06%
6 months+28.78%
Current year-3.74%
1 week 219.92
Extreme 219.92
233.75
1 month 219.92
Extreme 219.92
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Free

Director

13 0.0000%
30/10/26 Free

Director

193 0.0000%
30/10/26 Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-3.16%-5.43%-0.82%+4.42% 155B
-2.79%-4.38%+16.90%+42.75% 248B
-2.01%-10.04%-27.74%+28.17% 138B
-2.35%-5.32%-56.54%-22.92% 60.85B
-1.95%-4.95%+21.12%+51.59% 58.56B
-1.96%-2.25%+4.04%-14.08% 52.46B
-2.83%-2.06%+17.45%+49.48% 48.04B
-3.51%-4.30%+16.33%+68.80% 43.29B
+1.26%-11.71%-1.58%+48.97% 43.1B
-1.53%-2.87%+7.88%+9.97% 36.48B
Average -2.08%-4.08%-0.30%+26.72% 88B
Weighted average by Cap. -2.39%-3.83%+0.00%+27.04%

Financials

2026 *2027 *
Net sales 26.26B 23.92B 22.04B 20.05B 37.61B 2,432B 39.53B 268B 107B 1,328B 98.53B 96.46B 4,169B 28.28B 25.76B 23.74B 21.59B 40.51B 2,619B 42.57B 289B 115B 1,430B 106B 104B 4,489B
Net income 4.4B 4B 3.69B 3.36B 6.3B 407B 6.62B 44.91B 17.85B 222B 16.49B 16.15B 698B 5.22B 4.75B 4.38B 3.98B 7.47B 483B 7.85B 53.27B 21.17B 264B 19.57B 19.15B 828B
Net Debt 20.58B 18.74B 17.27B 15.71B 29.47B 1,906B 30.97B 210B 83.54B 1,041B 77.21B 75.58B 3,266B 16.09B 14.65B 13.5B 12.28B 23.04B 1,489B 24.21B 164B 65.3B 814B 60.35B 59.08B 2,553B
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
20/11/26 US$220.36 -3.16% 3,990,447
19/11/26 US$227.56 -0.45% 4,099,560
18/11/26 US$228.58 +1.24% 2,942,980
17/11/26 US$225.77 -1.80% 3,561,887
16/11/26 US$229.91 -1.33% 3,233,236
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
220.36USD
Average target price
259.90USD
Spread / Average Target
+17.95%